Clinical Trial Update: Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This update reports the termination of a Phase 1/Phase 2 trial of an autologous T cell therapy targeting viral oncoproteins in Merkel cell carcinoma, sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Drugs mentioned

• Viral oncoprotein targeted autologous T cell therapy

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED